E-LIB Suche - Ergebnisse für: Dotsu, Yosuke

1

Hypertrophic osteoarthropathy associated with lung cancer: ..:

Tagawa, Ryuta ; Soda, Hiroshi ; Dotsu, Yosuke...
Thoracic Cancer. 14 (2023) 14 - p. 1320-1324 , 2023

Link: https://doi.org/10.1111/..

2

Phase II study of IRInotecan treatment after COmbined chemo..:

Tomono, Hiromi ; Taniguchi, Hirokazu ; Fukuda, Minoru...
Thoracic Cancer. 14 (2023) 28 - p. 2890-2894 , 2023

Link: https://doi.org/10.1111/..

3

Phase II study of IRInotecan treatment after COmbined chemo..:

Hiromi Tomono ; Hirokazu Taniguchi ; Minoru Fukuda...
https://doi.org/10.1111/1759-7714.15097. , 2023

Link: https://doi.org/10.1111/..

4

Proportion of biopsy specimens containing a tumor when comp..:

Takemoto, Shinnosuke ; Ozasa, Mutsumi ; Mizuta, Remi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241111/. , 2023

Link: http://www.ncbi.nlm.nih...

5

Hypertrophic osteoarthropathy associated with lung cancer: ..:

Tagawa, Ryuta ; Soda, Hiroshi ; Dotsu, Yosuke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175026/. , 2023

Link: http://www.ncbi.nlm.nih...

6

Proportion of biopsy specimens containing a tumor when comp..:

Takemoto, Shinnosuke ; Ozasa, Mutsumi ; Mizuta, Remi...
10.2217/lmt-2022-0001. , 2023

Link: https://nagasaki-u.repo...

7

Hypertrophic osteoarthropathy associated with lung cancer: ..:

Ryuta Tagawa ; Hiroshi Soda ; Yosuke Dotsu...
https://doi.org/10.1111/1759-7714.14869. , 2023

Link: https://doi.org/10.1111/..

8

Phase II study of IRInotecan treatment after COmbined chemo..:

Tomono, Hiromi ; Taniguchi, Hirokazu ; Fukuda, Minoru...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542459/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Proportion of biopsy specimens containing a tumor when comp..:

Takemoto, Shinnosuke ; Ozasa, Mutsumi ; Mizuta, Remi...
Lung Cancer Management. 11 (2022) 4 - p. , 2022

Link: https://doi.org/10.2217/..

10

Chemical augmentation of mitochondrial electron transport c..:

Dotsu, Yosuke ; Muraoka, Daisuke ; Ogo, Naohisa...
Journal for ImmunoTherapy of Cancer. 10 (2022) 2 - p. e003958 , 2022

Link: https://doi.org/10.1136/..

11

Phase I study of amrubicin plus cisplatin and concurrent ac..:

Akagi, Kazumasa ; Taniguchi, Hirokazu ; Fukuda, Minoru...
Thoracic Cancer. 13 (2022) 16 - p. 2404-2409 , 2022

Link: https://doi.org/10.1111/..

12

Immunosuppressive tumor microenvironment in extraskeletal m..:

Ogata, Ryosuke ; Soda, Hiroshi ; Senju, Hiroaki...
Thoracic Cancer. 13 (2022) 19 - p. 2812-2816 , 2022

Link: https://doi.org/10.1111/..

13

Pan‐HER inhibitors overcome lorlatinib resistance caused by..:

Taniguchi, Hirokazu ; Akagi, Kazumasa ; Dotsu, Yosuke...
Cancer Science. 114 (2022) 1 - p. 164-173 , 2022

Link: https://doi.org/10.1111/..

14

Pan‐HER inhibitors overcome lorlatinib resistance caused by..:

Taniguchi, Hirokazu ; Akagi, Kazumasa ; Dotsu, Yosuke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807501/. , 2022

Link: http://www.ncbi.nlm.nih...

15

Immunosuppressive tumor microenvironment in extraskeletal m..:

Ryosuke Ogata ; Hiroshi Soda ; Hiroaki Senju...
https://doi.org/10.1111/1759-7714.14613. , 2022

Link: https://doi.org/10.1111/..